30th Jun 2020 21:12
Yourgene Health PLC - Manchester-based molecular diagnostics firm - Launches Clarigene SARS-CoV-2 test. Test determines whether virus is present in body and does not test for antibody presence. Yourgene said: "Yourgene already has over 300 laboratory customers and a growing global network of distribution channels in place through which to drive sales of the Clarigene SARS-CoV-2 test and CE IVD kits, once approved, targeting a pipeline of opportunities."
Current stock price: 16.55 pence
Year-to-date change: up 19%
By Eric Cunha; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
YGEN.L